Codes / ICD10CM / M1A.1590

M1A.1590 Lead-induced chronic gout, unspecified hip, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Unspecified Hip, Without Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This specific presentation affects the hip (unspecified side), resulting in persistent symptoms and potential tissue damage if untreated. The absence of tophi (tophi) indicates no visible urate crystal deposits in the affected area.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults

Symptoms

  • Recurrent episodes of intense joint pain in the hip
  • Persistent swelling, redness, and warmth in the affected area
  • Stiffness and limited hip mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage and confirms the hip as the affected site. The absence of tophi is noted during physical examination.

Treatment Options

  • Medication to reduce uric acid levels (e.g., allopurinol)
  • Anti-inflammatory drugs for pain and swelling
  • Lead exposure reduction or removal
  • Joint protection and mobility support

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels, adjust treatment, and address any complications. Long-term lead exposure cessation improves outcomes.

Complications

  • Chronic joint damage or deformity
  • Recurrent flare-ups
  • Kidney issues from prolonged hyperuricemia
  • Reduced mobility or function

Lifestyle & Prevention

  • Avoid lead exposure sources (e.g., contaminated water, old paint)
  • Maintain a balanced diet low in purines
  • Stay hydrated to support uric acid excretion
  • Follow occupational safety guidelines for lead handling

When to Seek Professional Help

Seek care if experiencing severe hip pain, swelling, or stiffness that interferes with daily activities. Prompt evaluation is needed for persistent symptoms or signs of infection.

Tips for Medical Coders

Use this code for lead-induced chronic gout affecting the hip (unspecified side) without tophi. Document the absence of tophi and confirm the hip as the affected site. Ensure lead exposure is clinically linked to the gout presentation.

Book a walkthrough

M1A.1590 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.